Cancer Research Cancer Epigenetics  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, S.-C.
Right arrow Articles by Su, L.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, S.-C.
Right arrow Articles by Su, L.-K.
[Cancer Research 62, 1311-1314, March 1, 2002]
© 2002 American Association for Cancer Research


Advances in Brief

Inhibition of Cancer Cell Growth by BRCA21

Shao-Chun Wang, Ruping Shao, Annie Y. Pao, Su Zhang, Mien-Chie Hung2 and Li-Kuo Su

Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

The breast cancer susceptibility gene BRCA2 has been suggested to function as a "caretaker" of the genome. Cells without wild-type BRCA2 are deficient in repairing DNA damage. However, whether BRCA2 can also suppress oncogenesis by regulating cell proliferation remains to be determined. To address this question, the expression of wild-type BRCA2 protein was reconstituted, in an either constitutive or regulated manner, in the pancreatic cancer cell line Capan-1, which expresses only a mutant BRCA2. Expression of wild-type BRCA2 inhibited cell proliferation in culture and suppressed tumor growth in animals. Our results showed that, in addition to the DNA repair function, BRCA2 also suppresses tumor development by inhibiting cancer cell growth.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
E. Gallmeier and S. E. Kern
Targeting Fanconi Anemia/BRCA2 Pathway Defects in Cancer: The Significance of Preclinical Pharmacogenomic Models
Clin. Cancer Res., January 1, 2007; 13(1): 4 - 10.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Moro, A. A. Arbini, E. Marra, and M. Greco
Up-regulation of Skp2 after Prostate Cancer Cell Adhesion to Basement Membranes Results in BRCA2 Degradation and Cell Proliferation
J. Biol. Chem., August 4, 2006; 281(31): 22100 - 22107.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Moro, A. A. Arbini, E. Marra, and M. Greco
Down-regulation of BRCA2 Expression by Collagen Type I Promotes Prostate Cancer Cell Proliferation
J. Biol. Chem., June 10, 2005; 280(23): 22482 - 22491.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X.-x. Tian, D. Rai, J. Li, C. Zou, Y. Bai, D. Wazer, V. Band, and Q. Gao
BRCA2 Suppresses Cell Proliferation via Stabilizing MAGE-D1
Cancer Res., June 1, 2005; 65(11): 4747 - 4753.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-R. Lin, N. S. Y. Ting, J. Qin, and W.-H. Lee
M Phase-specific Phosphorylation of BRCA2 by Polo-like Kinase 1 Correlates with the Dissociation of the BRCA2-P/CAF Complex
J. Biol. Chem., September 19, 2003; 278(38): 35979 - 35987.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.